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Abstract
Background: Acute respiratory distress syndrome (ARDS) is associated with vascular endothelial dysfunction.
The resultant microvascular reactivity can be assessed non-invasively using near-infrared spectroscopy (NIRS)
and a vascular occlusion test (VOT) and changes have been correlated with severity of organ dysfunction and
mortality in other critically ill populations. We used NIRS to study the presence of microcirculatory alterations
in patients with ARDS.
Methods: We studied 27 healthy volunteers and 32 ARDS patients admitted to our intensive care department. NIRS
measurements were performed within 24 h after diagnosis (Berlin definition). VOTs were performed by inflating an arm-
cuff to a pressure greater than the systolic pressure for 3 min, followed by rapid deflation. The descending (Desc) and
ascending (Asc) thenar muscle oxygen saturation (StO2) slopes were calculated. We compared data from volunteers
with those from ARDS patients, from ARDS survivors and non-survivors, and from ARDS survivors who required <7 days
ventilatory support (good evolution) with those who required >7 days support or died (poor evolution).
Results: ARDS patients had lower StO2 values [75(67–80) vs 79(76–81) %, p = 0.04] and Asc slopes [185(115–233) vs
258(216–306) %/min, p < 0.01] than healthy volunteers, but Desc slopes were similar. The Asc slope was lower in the
patients with a poor evolution than in the other patients [121(90–209) vs 222(170–293) %/min, p < 0.01], and in the
non-survivors than in the survivors [95(73–120) vs 212(165–252) %/min, p < 0.01].
Conclusions: In ARDS patients, microvascular reactivity is altered early, and the changes are directly related to the
severity of the disease. The ascending slope is the best determinant of outcome.
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Background
Acute respiratory distress syndrome (ARDS), defined
using the Berlin criteria [1], is diagnosed in 25 to 30 %
of patients admitted to the intensive care unit (ICU)
who need mechanical ventilation for more than 24 h
[2, 3], and is associated with high mortality rates [2–4]
and long term sequelae [5, 6]. The complex patho-
physiological alterations include functional and mor-
phological alterations in the pulmonary endothelium
[7], which may be correlated with the severity of the
disease and outcomes [8–10].
Different options are available to study this endothelial
dysfunction and the microcirculatory alterations that
take place during ARDS. Invasive studies can be per-
formed in animals to directly visualize the microcircula-
tion using intra-vital video-microscopy [11]; levels of
specific molecules (biomarkers) can be dosed in the
plasma or in the bronchoalveolar fluid [12]; biopsies can
be performed in selected cases [13]; or anatomo-
pathological studies can be performed in the lungs of pa-
tients who die [7]. All these approaches have advantages
and limitations. In clinical studies, the most invasive
techniques can often not be applied and measurement
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of concentrations of single biomarkers does not reflect
the complex underlying pathophysiology [14, 15].
Assessment of complex microvascular responses can
now be performed non-invasively at the patient’s bedside
using provocative tests of the microcirculation [16]. For
example, using near-infrared spectroscopy (NIRS) it is
possible to characterize the local muscle oxygen satur-
ation (StO2) by applying the properties of oxy- and
deoxy-hemoglobin to infrared light [17]. If the arterial
supply to a region is transiently obstructed by a vascular
occlusion test (VOT), the rate of decrease in the StO2
(desaturation) is a reflection of local oxygen consump-
tion [18], and the rate of increase (re-saturation) after
the VOT is related to the post-occlusive microcirculatory
vascular hyperemia [19]. This dynamic test has been
used to demonstrate that microvascular reactivity is
altered in patients with sepsis [20], multiple organ dys-
function [21], trauma [22], acute heart failure [23], car-
diac surgery [24] or after cardiac arrest resuscitation [25]
and that the changes are not entirely explained by global
hemodynamic variables. However, there are no data cur-
rently available in patients with ARDS. We, therefore,
used NIRS to evaluate the presence, severity and prog-
nostic implications of early microcirculatory alterations
in patients with ARDS.
Methods
This prospective, observational, non-invasive, physiological
study was conducted in the 35-bed Department of Intensive
Care of Erasme University Hospital (Brussels, Belgium). In-
stitutional Ethical Committee approval was obtained, and
all volunteers and patients (or their next of kin) provided
written informed consent.
Patients and volunteers
Healthy adult volunteers were recruited from the hos-
pital staff. Adult ICU patients with ARDS were enrolled
between October 2013 and June 2015 when they fulfilled
the Berlin diagnostic criteria [1], including a PaO2/FiO2
ratio ≤ 300 on mechanical ventilation with a positive
end-expiratory pressure (PEEP) of at least 5 cmH2O, and
the presence of bilateral infiltrates on chest radiography,
not explained by cardiogenic edema and in the presence
of a risk factor for ARDS. Patients were stratified for
severity using the PaO2/FiO2 ratio as recommended [1].
Patients were only included if a researcher was available
to perform the NIRS measurements. All patients were
managed according to current guidelines by a team of
intensivists different from the researchers who per-
formed the NIRS measurements.
Protocol
The healthy volunteers were placed in a quiet, temperature
controlled room within the department of intensive care,
where they rested, comfortably seated for at least 15 min
before the experiment. Heart rate (HR), respiratory rate
(RR) and hemoglobin saturation by pulse oximetry
(SpO2) were evaluated non-invasively with a Siemens
SC 9000 monitor (Siemens, Erlangen, Germany). Non-
invasive measurements of mean arterial pressure
(MAP) were obtained on the opposite arm to that used
for the NIRS measurements.
All patients were studied within 24 h after the diagnosis
of ARDS was made. At the time when the NIRS VOT was
performed, we recorded all measured hemodynamic and
respiratory parameters from the monitoring systems. Bio-
chemical and laboratory data closest to the time of the
VOT were also recorded as was the presence or absence
of any sedation. An APACHE II score [26] was calculated
using the worst data during the first 24 h in the ICU, and
a sequential organ failure assessment (SOFA) score [27]
from the data present at the time of the NIRS measure-
ments. We also recorded the duration of mechanical ven-
tilation until definitive weaning from ventilatory support
and calculated the ventilator-free days (VFD) at 28-days,
giving a value of zero to non-survivors.
Survivors who required less than 7 days (arbitrarily
selected) of respiratory support were classified as hav-
ing a good evolution and those who required more than
7 days of mechanical ventilation or who died as having
a poor evolution.
NIRS measurements
StO2 was measured using a near-infrared spectrom-
eter (InSpectra 850 model, Hutchinson Technology,
Hutchinson, Minnesota), with a 15 mm-probe at-
tached to a fixed position on the thenar eminence
(on the opposite hand from the arm with the invasive
arterial line monitoring if present). Healthy volunteers
and conscious patients were asked not to move their
hand during the procedure. When the StO2 values had
Fig. 1 Schematic representation of tissue oxygen saturation (StO2)
changes during a vascular occlusion test (VOT)
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been stable for 1 min, we induced a VOT by rapidly inflat-
ing a sphygmomanometer cuff wrapped around the ipsi-
lateral arm, to a pressure of 50 mmHg above the systolic
arterial pressure for a period of 3 min (time threshold),
followed by a rapid deflation. The StO2 curves were then
analyzed using dedicated software (In Spectra Software
Analyzer version 3.0., Hutchinson Technology). We mea-
sured the baseline, minimal and maximal StO2 (StO2base,
StO2min and StO2max, respectively) and total hemoglobin
index (THI base, THI min and THI max, respectively).
We also computed the StO2 ascending (Asc) and descend-
ing (Desc) slopes (Fig. 1).
Statistical analysis
Statistical analysis was performed using SPSS 22.0 (IBM,
New York, NY) software. Dependent variables were
assessed for normality of distribution using Skewness and
Kurtosis tests and Q-Q plots. All values are presented as




Total (n = 32) Good evolution (n = 16) Poor evolution (n = 16)
Age (years) 30 (27–31)* 63 (48–71) 68 (46–78) 61 (51–66)
Male n(%) 15 (56) 21 (66) 12 (75) 9 (56)
Body mass index (Kg/m2) 23 (22–25)* 26 (23–29) 25 (24–28) 27 (22–30)
Mean arterial pressure (mmHg) 88 (83–91) 82 (75–89) 83 (80–93) 78 (72–87)
Heart rate (bpm) 74 (70–79)* 95 (81–104) 96 (81–105) 95 (83–102)
Respiratory rate (bpm) 12 (12–13)* 24 (19–30) 23 (18–30) 24 (20–31)
SpO2 98 (98–99)* 97 (95–99) 97 (95–99) 98 (96–99)
Hemoglobin O2 saturation (%) - 97 (95–99) 97 (95–99) 98 (96–100)
Temperature (°C) - 37.0 (36.3-37.5) 37.1 (36.6-37.6) 36.7 (36.1-37.2)
Sepsis n(%) - 16 (50) 7 (44) 9 (56)
Primary ARDS n(%) - 9 (28) 5 (31) 4 (25)
Trauma n(%) - 4 (13) 2 (13) 2 (13)
Surgery n(%) - 18 (56) 12 (75) 6 (38)
Chronic lung disease n(%) - 5 (16) 1 (6) 4 (25)
Inspired O2 fraction (%) - 50 (40–55) 50 (33–50) 50 (40–70)
Positive end-expiratory pressure (cmH20) - 6 (5–8) 7 (6–8) 5 (5–11)
PaO2/FiO2 ratio - 172 (126–231) 181 (126–243) 172 (128–223)
pH - 7.39 (7.34-7.44) 7.40 (7.34-7.44) 7.38 (7.33-7.45)
PCO2 (mmHg) - 37 (36–44) 37 (36–43) 38 (35–53)
Lactate (mmol/L) - 1.4 (0.8-2.5) 1.4 (0.8-3.2) 1.5 (0.9-2.3)
Creatinine (mg/dL) - 1.1 (0.7-1.6) 1.1 (0.8-1.4) 1.0 (0.6-2.0)
Renal replacement therapy n(%) - 4 (13) 1 (6) 3 (19)
Total bilirubin (mg/dL) - 0.7 (0.5-1.1) 0.6 (0.5-1.1) 0.8 (0.6-1.3)
Platelets (x103/μL) - 129 (91–197) 143 (84–226) 121 (95–192)
Leukocytes (cells x103/μL) - 13.0 (9.4-16.7) 13.9 (11.9-16.2) 11.7 (7.6-17.9)
Hemoglobin (mg/dL) - 9.6 (8.9-11.2) 9.6 (9.0-10.8) 9.7 (8.6-11.5)
Sedation n(%) - 19 (59) 8 (50) 11 (69)
APACHE II score - 22 (19–26) 21 (18–23) 25 (21–28)**
SOFA score - 9 (7–13) 8 (5–11) 11 (7–15)
Norepinephrine (mcg/Kg/min) - 0.01 (0.00-0.17) 0.00 (0.00-0.05) 0.07 (0.00-0.27)
Dobutamine (mcg/Kg/min) - 0 (0–3) 0 (0–2) 0 (0–5)
ICU length of stay (days) - 7.7 (4.4-13.7) 6.0 (4.0-7.7) 11.9 (7.3-20.6)**
Ventilator free days at 28 days (days) - 21 (0–25) 25 (24–26) 0 (0–17)**
Mortality n(%) - 8 (25) 0 (0) 8 (50)**
*significant difference at the p <0.05 level versus ARDS patients; **significant difference at the p <0.05 level versus good evolution
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median values with percentiles (25–75 %), unless other-
wise specified. Categorical data are presented as numbers
of events and percentages. Comparisons between different
cohorts were performed using a t-test, Mann–Whitney U
test or Kruskal-Wallis H test as appropriate. Proportions
were compared with a Chi square test or Fisher’s exact
test as appropriate. A binary logistic regression was per-
formed to identify the role of different variables to predict
poor evolution, calculating the odds ratio (OR) and its re-
spective 95 % confidence interval (CI). All variables that
presented a p value < 0.1 during the univariate analysis
were introduced into a multivariate analysis. We plot-
ted the sensitivities and specificities in receiving operat-
ing characteristic (ROC) graphs and the area under the
curve (AUC) was calculated for the different variables.
A 2-sided p value less than 0.05 was considered as sig-
nificant for all analyses.
Results
Twenty-seven healthy volunteers were recruited (mean
age 30 [range 27–31] years; 15 male) and 32 patients
with ARDS (mean age 63 [range 48–71], 21 male). The
main demographic, clinical and biochemical characteris-
tics of the volunteers and patients are presented in
Table 1. The characteristics of ARDS survivors and non-
survivors are shown in Additional file 1: Table S1.
NIRS derived parameters are shown in Table 2. ARDS
patients had lower StO2 values and Asc slope, but not
Desc slope, than healthy volunteers. Patients with a
poor evolution had a lower NIRS Asc slope than
those with a good evolution (Fig. 2a), but StO2 and
Desc slope values were not significantly different
(Table 2). Likewise, non-survivors had a lower NIRS
Asc slope than survivors (Fig. 2b). There were no
differences in the Asc slope values according to the
cause of ARDS (including sepsis and its severity)
(Additional file 1: Figure S1 and S2).
There were no significant differences in the PaO2/
FiO2 ratio between patients with a good or poor evolu-
tion, or between survivors and non-survivors (Tables 1
and Additional file 1: Table S1). However, ARDS pa-
tients with a PaO2/FiO2 ratio < 100 had a lower NIRS
Asc slope than those with a PaO2/FiO2 ratio between
201 and 300 (Fig. 3).
The NIRS Asc slope was a better predictor of poor
evolution (and of mortality alone) than the PaO2/FiO2
ratio (Fig. 4). This was confirmed in the multivariate
analysis in which the NIRS Asc slope was the most




Total (n = 32) Good evolution (n = 16) Poor evolution (n = 16) Survivors (n = 24) Non-survivors (n = 8)
StO2 base (%) 79 (76–81) 75 (67–80)* 77 (72–80) 74 (60–80) 77 (73–80) 60 (59–76)*
THI base (au) 14.4 (12.8-15.4) 9.6 (6.8-10.8)** 9.7 (7.7-10.8) 9.0 (6.8-10.9) 9.8 (6.8-10.8) 7.9 (6.7-11.7)
StO2 max (%) 94 (90–94) 85 (76–90)** 87 (82–90) 84 (73–90) 87 (83–93) 73 (70–84)*
Desc slope (%/min) 10.3 (8.4-11.4) 9.6 (8.2-13.4) 11.3 (8.7-15.8) 8.8 (7.2-13.2) 11.3 (8.7-15.3) 8.1 (5.7-9.1)**
Asc slope (%/min) 258 (216–306) 185 (115–233)** 222 (170–293) 121 (90–209)** 212 (165–252) 95 (73–120)**
* = p < 0.05 and ** = p < 0.01, ARDS patients compared to healthy volunteers, poor evolution compared to good evolution, and non-survivors compared to survivors
Fig. 2 NIRS Asc slope in healthy volunteers and patients with ARDS according to evolution (a) and survival status (b). * = p < 0.05 compared with the
volunteers; $ = p < 0.05 compared with patients with good evolution; # = p < 0.05 compared with the survivors
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significant factor associated with a poor evolution during
the ICU stay (Additional file 1: Tables S2 and S3).
Discussion
The main finding of our study is that ARDS patients
have altered peripheral microvascular reactivity as
assessed using NIRS. This alteration is directly related to
the severity of the disease characterized as death and/or
prolonged need for mechanical ventilation.
The only published data on microcirculatory alter-
ations in humans with acute respiratory failure assessed
using non-invasive techniques were reported by our
group in a small series of patients with acute lung injury
due to Influenza AH1N1 [28]. These patients had di-
minished capillary density in the sublingual area, with
a low proportion of perfused vessels and a reduced
microvascular flow index. In the thenar muscle, post-
occlusive reactive hyperemia was impaired, as mani-
fest by low values of the Asc slope, similar to those
found in septic patients in other studies [29–31]. Our
current study extends these data to a larger and more
heterogeneous population of patients with ARDS.
Half of the patients in our study had sepsis, but micro-
circulatory alterations detected by NIRS are not pathog-
nomonic of septic conditions. Numerous studies have
shown alterations of the Asc slope in septic populations,
especially in the presence of shock [20, 29, 30], but low
values of the Asc slope have also been observed in other
acute conditions (normal values of 288 and 323 %/min
have been reported [20, 22]): Gomez et al. reported
values of 172 ± 103 %/min in trauma patients [22];
Petroni et al. reported values of 77 ± 42 %/min in pa-
tients with severe acute heart failure requiring veno-
arterial extracorporeal membrane oxygenation (ECMO)
support [23]; Morel et al. reported values of 144 (126–
228) %/min 6 h after cardiopulmonary bypass in patients
who had undergone cardiac surgery [24]; Donadello et
al. reported values of 68 ± 32 %/min in resuscitated car-
diac arrest patients after cessation of therapeutic
hypothermia [25]; and we previously reported values of
186 ± 89 %/min in patients with circulatory shock of dif-
ferent etiologies [31]. In the present study, patients with
septic shock had similar Asc slope values to patients
with ARDS of non-septic causes. Although the mecha-
nisms involved in the control of post-occlusive reactive
hyperemia (NIRS Asc slope) have not been completely
identified and are sometimes controversial [32, 33], it is
well known that multiple vasodilator pathways (e.g., ni-
tric oxide and prostaglandins) are necessary to obtain
the transient increase in local blood flow [32] and com-
plex inflammatory alterations will have been present in
Fig. 3 NIRS Asc slope in ARDS patients according to their PaO2/FiO2
ratio. * = p < 0.05 compared with the patients with a PaO2/FiO2 ratio
between 201–300
Fig. 4 Receiver operating characteristic (ROC) curves for Asc slope and PaO2/FiO2 ratio to predict death (right panel) or poor evolution (death or
more than 7 days of mechanical ventilation; left panel)
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all the populations studied above [20, 22–25, 31]. Thus,
the NIRS VOT is a functional test of the microcircula-
tion, which measures its reserve (recruitability) under
controlled ischemia, and involves multiple pathways.
Our findings suggest that microvascular endothelial
dysfunction is present in the earliest stages of ARDS and
is correlated with its severity. This concept fits well with
the elevated concentrations of various pro-inflammatory
molecules seen in patients with ARDS [8, 12, 34] and with
autopsy findings revealing an initial pro-inflammatory and
exudative phase [7, 35]. Dolinay and colleagues performed
a series of experiments in mice and various cohorts of
ARDS patients and showed that several inflammasome-
regulated cytokines, including interleukin-18, play a major
role in the development of ARDS [36]. Orfanos and col-
leagues demonstrated that severe ARDS was associated
with decreased pulmonary capillary endothelium-bound
angiotensin converting enzyme (ACE) function in vivo (an
indirect marker of endothelial injury) [37]. More recently,
Moussa et al. demonstrated that patients with ARDS in
the context of sepsis had elevated numbers of circulating
endothelial cells (a direct marker of endothelial injury),
which were correlated with severity [10].
Early prognostication of outcome in ARDS is challen-
ging. In large databases, the mortality rate is directly
related to the severity of the alterations in gas exchange
as expressed by the PaO2/FiO2 ratio, but the relationship
is not very strong [38, 39], with an AUC of only 0.58 in
a recent multicenter study [1]. We used a main com-
bined outcome of death or need for prolonged mechan-
ical ventilation which is essentially the opposite of
ventilator-free days [40], but we also observed positive
results when mortality was considered alone. Previous
investigators have tried to predict similar combined out-
comes, but they needed to use clinical data obtained
during the first three days of hospitalization [41], rather
than just on the first day as in the present study. Other
groups have developed scores mixing various clinical
and demographic data at admission, but these were not
superior to the APACHE II score for predicting mortal-
ity [42]. We also observed that those patients who recov-
ered rapidly had a similar Asc slope when compared with
volunteers, despite the severe hypoxemia. Additionally,
the NIRS Asc slope was the best predictor for death or
more than 7 days on mechanical ventilation. Together
these observations suggest that performing a NIRS VOT
test on the first day of ARDS enables identification of pa-
tients at high-risk of poor outcome, potentially creating a
target population for the testing of early interventions.
Our study has some limitations. First, it was a monocen-
ter study and patient enrolment depended on researcher
availability, although we included a heterogeneous sample
of patients with different severities of ARDS. Second, we
performed a single measurement and the time course of
the Asc slope during subsequent days of treatment may
provide additional information, as has been shown in sep-
tic patients [20]. Third, our control group was comprised
of healthy younger individuals who may have different
vascular reactivity to that of ARDS patients. However, we
have previously reported that NIRS values are quite simi-
lar in control cohorts of patients and in healthy younger
volunteers [20, 31]. Our comparison enables the whole
spectrum from the normal values of health to those in
severe ARDS patients to be considered. Finally, the sample
size of our population was small, potentially explaining
the non-significant differences in some variables, for ex-
ample, the norepinephrine doses between patients with
good and poor evolution (Table 1) or the NIRS Asc slope
in the different groups of PaO2/FiO2 ratios, despite trends
in the data. Nevertheless, the clinical relevance of the
NIRS Asc slope was higher than that of other studied vari-
ables and this variable needs to be investigated further.
Conclusion
In ARDS patients, there is an early, marked alteration in
microvascular reactivity, which is directly related to the
severity of the disease as reflected by the duration of
mechanical ventilation and mortality.
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